ArticleAntibodies (Basel, Switzerland)2022

Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability.

Dennis R Goulet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.